Criteria

The primary author (first and/or corresponding author) must be a member of APhA. The paper must represent original research and have been published in JAPhA within 2 calendar years prior to the screening deadline.

The Screening Committee will evaluate papers based upon the following criteria (not in rank order):

• Potential of the paper to translate clinical science or practice-based investigations into practice
• Quality of the science (quality factors may include but are not limited to: adequate sample size, use of control groups, statistical analysis, research is not purely descriptive, research includes an evaluation component, etc.)
• The research should describe a rigorous evaluation of a well-designed patient care intervention or practice-based initiative
• The research is original and innovative while being founded in existing literature and/or theory
• The research has had or is likely to have a significant impact on practice, the profession, or medication use

Nomination/Screening process

A Screening Committee comprised of members of the Clinical Sciences Section of the APhA Academy of Pharmaceutical Research and Science (APhA-APRS) will screen all eligible papers published in JAPhA in the previous 2 years and select and submit three finalists to the APhA-APRS Awards Committee by the screening deadline (September 15).

Selection process

The selection of the recipient is made by the APhA-APRS Awards Committee.

Nature of award

The nature of the award presented at the APhA Annual Meeting & Exposition will consist of an engraved plaque for each author of the selected paper. The primary author also receives a complimentary APhA Annual Meeting & Exposition registration and reimbursement for meeting-related travel expenses, according to current travel policies and up to the maximum amount budgeted by APhA.